Stem Cell Therapy
STEM CELL THERAPY
Unit 5 Assessment Research
Santana Montemayor
10/10/2021
Herzing University
English Composition II
Professor Taylor
Introduction
Regenerative medicine and new biotechnologies have the potential to transform medical practice. Tissue regeneration has become a therapeutic possibility thanks to advances in stem cell biology, including embryonic and postnatal somatic stem cells. In the absence of reproductive cloning, these technologies could create replacement tissue for the defective host. The researcher has provided a literature review on stem cell therapy in this article, taking into account the research done in the same areas as shown below.
The conjugated nanoparticles – nanoconjugates – have been widely used in the treatment of autoimmune sickness, cancer, and circulatory illnesses, as well as in the treatment of major illnesses or HBP, thanks to the stimulating the T cells or NK cells and acting as regenerative drugs, using the thought of cellular manufacturing (Desai and Shende, 2020). Nanoconjugates are nanocarriers for active compounds with a long-acting healing effect (Desai and Shende, 2020).
Because ASCs are heterogeneous, each time they are used in clinical applications, they should be described. Phenotypic validation is a component of the safety assessment that confirms the isolated and expanded cell population is indeed MSC phenotype (Ntegeab, Sunamib & Shimizu, 2020). As part of the requirements for employing the cells in clinical applications, the immunophenotypic analysis should be undertaken after the isolation and expansion phases.
In the work of (Wojciech, Maciej, maria, and Zbigniew 2019), it is demonstrated that stem cell therapy has emerged to be one of the most promising advances in scientific research. This has led to the development and improvement in the treatment mechanisms that have evoked significant expectations. The primary focus of the study was to discover the various stem cells and the potential therapy used which are available to each of them. The derivation mechanisms and use of the culturing media are significant in developing the appropriate environmental conditions for the controlled differentiation. The various strategies that stem cell therapy has to overcome are widely discussed as stem cells are depicted as having capacities of differentiating and dividing into multiple cells of the entire organism. The impacts of the sperm cell specialization procedures are further divided into external and internal, with the former being the physical contact between these cells or the chemical secretion associated with the surrounding tissue and the latter being controlled by the genes generated by the DNA.
In their work (Prathiparty and Kameswararo 2015) argue that stem cell therapy is a section of regenerative medicine characterized by the utilization of the undifferentiated cells in The Killing of an illness. As demonstrated in the article, stem cell therapy is further explored in treating various conditions counting neurodegenerative conditions; the party's on infection, cardiovascular sickness, liver sickness, diabetes, and others. Stem cell therapy is focused on the alleviation of Challenges associated with the current treatment modalities, which are demonstrated to leave the patient with a certain degree of mobility they provide short-term and symptomatic relief. The emergence of stem cell therapy is regarded to be playing a critical role in directing scientific explanations, add to the scientist in the era of increased research on the possible and potential care intervention modalities for oral cancer.
The ability of diverse organs and tissues to regenerate is lost as people age, making them more vulnerable to aggressiveness and diminished function. Tendon getting old is a complex process that shares similar appliances with other tissues. According to the suggested "Hallmarks of Aging" model by López-On et al ., Tendon construction and cellular configuration are also distinct, making scientific investigation in this topic both specialized and challenging. Tendon stem/progenitor cells (TSPCs), a subset of Mesenchymal Stem Cells (MSCs), may be crucial.
Researchers have recently been inspired by discovering prompted pluripotent stem cells (iPSCs), predominantly cells extracted from mature adults, to create possible medicines to cure clinical disorders and ponder the age-old question of how to reclaim our youth Costa-(Almeida, Calejo, Gomes 2019). As a result, iPSCs gave inspiration for reversing stem cell fate by manipulating cell growth factors. Both the endogenic differentiation of these iPSCs and pre-MSCs was improved by mechanical stretching. As vital as it is to comprehend the causes of tendon aging, it is also critical to appreciate how the old tendon responds to various stimuli.
A variety of circumstances influences tendon homeostasis. The properties of TSPCs are altered by macroscopic factors accompanying the rough exercise intensity and microscopic influences connected with a compromised estrogen equilibrium, deteriorating ECM situations, and improper drug usage, particularly as people age (Chen, Zhang, Liu, Zhu, Shen, et al. 2016). There is currently no optimal treatment method for human musculoskeletal injuries, particularly tendon injuries. Topics have the potential to usher in a new age in the treatment of various types of damages, whether they are stimulated or transplanted.
Mesenchymal stem cell (MSC) therapy has been proven successful in tissue regeneration in cardiovascular disease, with immunomodulatory and anti-inflammatory special effects such as macrophage polarity and increased anti-inflammatory cytokine release (Beaudoin, Dal-Bianco, Aikawa, Bischoff, Guerrero, et al. 2017). We just created a novel approach, dubbed "Stem cell technology," to improve the efficacy of MSC therapy.
Allogeneic stem cells are effective and safe in several trials. While an off-the-shelf stem cell product may seem ideal, long-term immunogenicity problems remain since allogeneic cells. At the same time, immunological neutral or immune elusive will develop into the donor's resistant features. Short- or long-term allergic or immunological responses are not a concern with autologous stem cells. In addition, any infectious organisms must be absent from an allogeneic basis of humanoid stem cells. Because people are not raised in sterile surroundings, it is nearly hard to guarantee that allogeneic foundations are free of potentially infectious prions or viruses (King & Perrin, 2014). Risks of sickness spread from a range of allogeneic causes have already been highlighted in several articles.
Patients with paining knees osteoarthritis may help from having adipose stromal vascular fraction (SVF) surgically separated from lipoaspirate at the point of care. Patients may also send their autologous adipose materials to a workroom piling facility for cGMP generation and preservation of Mesenchymal Stem Cells (MSCs) for imminent use or recurrence management at the time of treatment. Nonetheless, same-day autologous cell therapy (SVF) eliminates the need for cGMP laboratory preparation (Yamanaka, 2020).
References
Primary sources
Beaudoin J, Dal-Bianco JP, Aikawa E, Bischoff J, Guerrero JL, et al. (2017) Mitral leaflet changes following myocardial infarction: Clinical evidence for maladaptive valvular remodeling. Circ Cardiovasc Imaging 10: e006512.
Chen J, Zhang W, Liu Z, Zhu T, Shen W, et al. (2016) Characterization and comparison of post-natal rat Achilles tendon-derived stem cells at different development stages. Sci Rep 6: 22946.
Costa-Almeida R, Calejo I, Gomes M (2019) Mesenchymal stem cells empowering tendon regenerative therapies. Int J Mol Sci 20: 3002.
King, N. M., & Perrin, J. (2014). Ethical issues in stem cell research and therapy. Stem Cell Research & Therapy, 5(4), 85. doi:10.1186/scrt474
López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153: 1194-1217.
Ntegeab, Sunamib & Shimizu. (2020). Advances in regenerative therapy: A review of the literature and future directions. Retrieved from https://www.sciencedirect.com/science/article/pii/S2352320420300043
Prathipa & Kameswararao. (2015, August 6). (PDF) Literature review on stem cell treatment & oral submucous fibrosis (Osmf). Retrieved from https://www.researchgate.net/publication/283333062_LITERATURE_REVIEW_ON_STEM_CELL_TREATMENT_ORAL_SUBMUCOUS_FIBROSIS_OSMF
Secondary sources
Shende & Desai. (2020). Physiological and therapeutic roles of neuropeptide Y on biological functions.
Wojciech, Maciej , Maria & Zbigniew. (2019, February 26). Stem cells: Past, present, and future. Retrieved from https://stemcellres.biomedcentral.com/articles/10.1186/s13287-019-1165-5
Yamanaka, S. (2020). Pluripotent stem cell-based cell therapy—Promise and challenges. Cell Stem Cell, 27(4), 523-531. doi:10.1016/j.stem.2020.09.014